866-997-4948(US-Canada Toll Free)

Mallinckrodt LLC - Product Pipeline Analysis, 2018 Update

Published By :

GlobalData

Published Date : Sep 2018

Category :

Medical Equipments

No. of Pages : 32 Pages

Summary

Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation in the presence of the photoactive drug 8-methoxypsoralen. Its treatment offers relief from the skin manifestations of cutaneous T-cell lymphoma (CTCL) in patients not responding to other forms of treatment. Mallinckrodt also provides innovative treatment platforms that harness the patients' immune systems to fight diseases such as cystic fibrosis, graft versus host disease, and peripheral T-cell lymphoma. The company serves academic medical centers, hospitals, and treatment centers in the US. Mallinckrodt is headquartered in St. Louis, Missouri, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Mallinckrodt LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Mallinckrodt LLC Company Overview 4
Mallinckrodt LLC Company Snapshot 4
Mallinckrodt LLC Pipeline Products and Ongoing Clinical Trials Overview 4
Mallinckrodt LLC Pipeline Analysis Overview 6
Mallinckrodt LLC - Key Facts 6
Mallinckrodt LLC - Major Products and Services 7
Mallinckrodt LLC Pipeline Products by Development Stage 8
Mallinckrodt LLC Ongoing Clinical Trials by Trial Status 10
Mallinckrodt LLC Pipeline Products Overview 12
CELLEX System - Crohn's Disease 12
CELLEX System - Crohn's Disease Product Overview 12
CELLEX System - Graft Versus Host Disease 13
CELLEX System - Graft Versus Host Disease Product Overview 13
EpiReady 14
EpiReady Product Overview 14
ExpressGraft - Antineoplastic 15
ExpressGraft - Antineoplastic Product Overview 15
ExpressGraft C9T1 Skin Tissue 16
ExpressGraft C9T1 Skin Tissue Product Overview 16
ExpressGraft C9T1 Skin Tissue Clinical Trial 17
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers 18
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers Product Overview 18
ExpressGraft Pro-Angiogenic - Venous Leg Ulcers 19
ExpressGraft Pro-Angiogenic - Venous Leg Ulcers Product Overview 19
Mallinckrodt LLC - Key Competitors 20
Mallinckrodt LLC - Key Employees 21
Mallinckrodt LLC - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Mallinckrodt LLC, Recent Developments 23
Mar 20, 2018: Mallinckrodt Announces First Investigator Award for Pioneering Efforts in ECP Immunomodulation 23
Feb 27, 2018: TGA Safety Alert On Therakos Cellex Photopheresis System 23
Feb 19, 2018: New VaxArray Potency Test Kit for Pandemic Flu Vaccines 24
Feb 14, 2018: Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft C9T1 Skin Tissue 24
Sep 05, 2017: Mallinckrodt Statement on Praxair Patent Infringement Ruling 25
May 03, 2017: Mallinckrodt Celebrates 30th Anniversary of THERAKOS Photopheresis Therapy 25
Oct 20, 2016: Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Five U.S States 26
Sep 23, 2016: Validity of Mallinckrodt's INOMAX Patent Claims Upheld 26
Sep 23, 2016: Validity of Mallinckrodt's INOMAX Patent Claims Upheld 27
Aug 23, 2016: Extracorporeal Photopheresis, Including Mallinckrodt's THERAKOS ECP Immunomodulation, Receives Approval for Reimbursement by Swiss Federal Department of Home Affairs 27
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Mallinckrodt LLC Pipeline Products and Ongoing Clinical Trials Overview 4
Mallinckrodt LLC Pipeline Products by Equipment Type 5
Mallinckrodt LLC Pipeline Products by Indication 5
Mallinckrodt LLC Ongoing Clinical Trials by Trial Status 5
Mallinckrodt LLC, Key Facts 6
Mallinckrodt LLC, Major Products and Services 7
Mallinckrodt LLC Number of Pipeline Products by Development Stage 8
Mallinckrodt LLC Pipeline Products Summary by Development Stage 9
Mallinckrodt LLC Ongoing Clinical Trials by Trial Status 10
Mallinckrodt LLC Ongoing Clinical Trials Summary 11
CELLEX System - Crohn's Disease - Product Status 12
CELLEX System - Crohn's Disease - Product Description 12
CELLEX System - Graft Versus Host Disease - Product Status 13
CELLEX System - Graft Versus Host Disease - Product Description 13
EpiReady - Product Status 14
EpiReady - Product Description 14
ExpressGraft - Antineoplastic - Product Status 15
ExpressGraft - Antineoplastic - Product Description 15
ExpressGraft C9T1 Skin Tissue - Product Status 16
ExpressGraft C9T1 Skin Tissue - Product Description 16
ExpressGraft C9T1 Skin Tissue - An Open-label, Prospective, Safety, and Tolerability Study of ExpressGraft-C9T1 Skin Tissue in the Treatment of Diabetic Foot Ulcers 17
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status 18
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description 18
ExpressGraft Pro-Angiogenic - Venous Leg Ulcers - Product Status 19
ExpressGraft Pro-Angiogenic - Venous Leg Ulcers - Product Description 19
Mallinckrodt LLC, Key Employees 21
Mallinckrodt LLC, Other Locations 22
Mallinckrodt LLC, Subsidiaries 22
Glossary 31

List of Figures
Mallinckrodt LLC Pipeline Products by Equipment Type 5
Mallinckrodt LLC Pipeline Products by Development Stage 8
Mallinckrodt LLC Ongoing Clinical Trials by Trial Status 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *